Act Capital Management, LLC Cyteir Therapeutics, Inc. Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
A detailed history of Act Capital Management, LLC transactions in Cyteir Therapeutics, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 15,000 shares of CYT stock, worth $45,150. This represents 0.04% of its overall portfolio holdings.
Number of Shares
15,000
Previous 15,000
-0.0%
Holding current value
$45,150
Previous $45,000
35.56%
% of portfolio
0.04%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding CYT
# of Institutions
6Shares Held
6.18MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN3.65MShares$11 Million7.36% of portfolio
-
Oup Management Co., LLC2.46MShares$7.4 Million15.71% of portfolio
-
Acadian Asset Management LLC Boston, MA26.3KShares$79,2200.0% of portfolio
-
Boston Family Office LLC Boston, MA24.2KShares$72,8320.01% of portfolio
-
Lindbrook Capital, LLC2.01KShares$6,0380.0% of portfolio
About Cyteir Therapeutics, Inc.
- Ticker CYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,413,400
- Market Cap $107M
- Description
- Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...